-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on IGM Biosciences, Lowers Price Target to $2

Benzinga·01/10/2025 17:13:00
Listen to the news
Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price target from $12 to $2.